Oncology expansion

[Anonymous]

I heard a rumor we are adding reps in oncology? Is this true? Think they will take internal people?

 

[anonymous]

Some of openings posted today. Not sure if more states are to come

 

[anonymous]

Recent history has repeatedly shown that GSK is incapable of capitalizing on real opportunities in the oncology sector.

GSK missed the opportunity 20 years ago when other pharmaceutical companies seized the chance to grow and expand their oncology portfolios. While GSK has intermittently entered the field with little success, the recent announcement of new account positions may give a false impression of growth and potential in this area.

Don’t be misled. With subpar products and recycled talent from underperforming internal divisions, GSK’s oncology efforts are likely to result in another short-lived failure. It's best to avoid GSK's oncology division.

 

[anonymous]

Recent history has repeatedly shown that GSK is incapable of capitalizing on real opportunities in the oncology sector.

GSK missed the opportunity 20 years ago when other pharmaceutical companies seized the chance to grow and expand their oncology portfolios. While GSK has intermittently entered the field with little success, the recent announcement of new account positions may give a false impression of growth and potential in this area.

Don’t be misled. With subpar products and recycled talent from underperforming internal divisions, GSK’s oncology efforts are likely to result in another short-lived failure. It's best to avoid GSK's oncology division.

Sounds about right.